Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Laboratorios Roemmers S.A.I.C.F.
- Target Recruit Count
- 135
- Registration Number
- NCT04463264
- Locations
- 🇦🇷
Hospital Universitario Austral, Presidente Derqui, Buenos Aires, Argentina, Argentina
© Copyright 2025. All Rights Reserved by MedPath